Juan Pinelli
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Surgery 3
- Bladder and Urothelial Cancer Treatments 3
- Urinary and Genital Oncology Studies 2
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Jonathan E. Rosenberg (3 shared papers)Evan Y. Yu (3 shared papers)Arjun Vasant Balar (3 shared papers)Bradley A. McGregor (3 shared papers)Peter H. O’Donnell (3 shared papers)Daniel P. Petrylak (3 shared papers)Amal Melhem‐Bertrandt (2 shared papers)Elaina M. Gartner (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (3 papers)Bone Marrow Transplantation (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Juan Pinelli
8 papers receiving 682 citations
Juan Pinelli's Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 259
- Pathology and Forensic Medicine 153
- Dermatology 71
- Surgery 315
- Immunology 73
Countries citing papers authored by Juan Pinelli
This map shows the geographic impact of Juan Pinelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Pinelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Pinelli more than expected).
Fields of papers citing papers by Juan Pinelli
This network shows the impact of papers produced by Juan Pinelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Pinelli. The network helps show where Juan Pinelli may publish in the future.
Co-authors
The 25 scholars most cited alongside Juan Pinelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy Hit paper breakdown → | 2019 | 456 |
| 2 | 2017 | 172 | |
| 3 | 2019 | 39 | |
| 4 | 2016 | 14 | |
| 5 | 2016 | 5 | |
| 6 | 2019 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 |
About Juan Pinelli
Juan Pinelli is a scholar working on Surgery, Pathology and Forensic Medicine, Dermatology, Oncology and Infectious Diseases, having authored 8 papers that have together received 691 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Urinary and Genital Oncology Studies (2 papers), Diabetes Management and Research (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (259 citations), Pathology and Forensic Medicine (153 citations), Dermatology (71 citations), Surgery (315 citations) and Immunology (73 citations). Juan Pinelli has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jonathan E. Rosenberg, Evan Y. Yu, Arjun Vasant Balar, Bradley A. McGregor, Peter H. O’Donnell, Daniel P. Petrylak, Amal Melhem‐Bertrandt, Elaina M. Gartner, Elisabeth I. Heath and Noah M. Hahn. Their work appears in journals such as Journal of Clinical Oncology, Blood, Bone Marrow Transplantation and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.